BeStock  
Stocks › Biotechnology › ASND

Ascendis Pharma A/S ASND

US equityMarket cap rank #681Biotechnology
$227.45 −$0.38 (-0.17%)
Market open · Oct 1, 1:10 pm ET · After hours $227.83 0.00%
Open$228.03
Prev close$227.83
Day range$226.76 – $229.66
Volume395.6K
Market cap$14.97B
P/E (TTM)17.9
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings18.0x
CheapRich

Near the top of its 5-year range · 92nd percentile, 5-year average -15.5x

#1445 of 2977 stocks by PE (1 = cheapest)

Price / book9.2x
CheapRich

Above its usual level · 67th percentile, 5-year average -19.2x

#4814 of 5307 stocks by PB (1 = cheapest)

Price / sales12.7x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 224.0x

#4498 of 5144 stocks by PS (1 = cheapest)

Morningstar fair value estimate

Fair value$184.57
Price vs. fair value+23.2%Trading above the estimate
Star rating★★☆☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 9.21 – -19.20 67% (pricier than usual) #4814 of 5307 (1 = cheapest)
PE 17.97 32.30 -15.53 92% (pricier than usual) #1445 of 2977 (1 = cheapest)
PS 12.67 7.72 224.05 0% (cheaper than usual) #4498 of 5144 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★
Fair value estimate$184.57
Economic moatNarrow
UncertaintyHigh

Discussion

No comments yet — be the first to weigh in on ASND.

Leave a comment

Scroll to Top